These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2112354)

  • 1. The lupus anticoagulant and retinal vaso-occlusive disease.
    Fitzpatrick EP; Chesen N; Rahn EK
    Ann Ophthalmol; 1990 Apr; 22(4):148-52. PubMed ID: 2112354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
    Reisin LH; Reisin I; Darawshi A; Aviel E
    Ann Ophthalmol; 1989 Jul; 21(7):269-71. PubMed ID: 2505658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus and anti-phospholipid syndrome.
    Chang PC; Chen WS; Lin HY; Lee HM; Chen SJ
    Lupus; 2010 Feb; 19(2):206-9. PubMed ID: 19880552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal vascular complications in systemic lupus erythematosus].
    Streicher T; Spirková J
    Cesk Slov Oftalmol; 2001 Sep; 57(5):321-8. PubMed ID: 11764689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant.
    Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM
    Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of retinal vascular involvement in systemic lupus erythematosus].
    Ermakova NA; Alekberova ZS; Kosheleva NM; Reshetniak TN
    Vestn Oftalmol; 2001; 117(2):21-4. PubMed ID: 11510158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral central retinal artery occlusion and vein occlusion complicated by severe choroidopathy in systemic lupus erythematosus.
    Nishiguchi KM; Ito Y; Terasaki H
    Lupus; 2013 Jun; 22(7):733-5. PubMed ID: 23681406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for lupus anticoagulant: the sensitivity of different assays.
    Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
    Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral central retinal vein occlusion and circulating anticoagulant].
    Lureau MA; Glacet-Bernard A; Coscas G
    J Fr Ophtalmol; 1995; 18(6-7):468-72. PubMed ID: 7560789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lupus anticoagulant in systemic lupus erythematosus.
    Rowell NR; Tate GM
    Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral vaso-occlusive retinopathy in quiescent condition of systemic lupus erythematosus.
    Hayasaka S; Furuse N; Kanamori M; Setogawa T
    Hiroshima J Med Sci; 1989 Mar; 38(1):35-8. PubMed ID: 2753745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody.
    Nakamura H; Uehara H; Okada T; Kambe H; Kimura Y; Ito H; Hayashi E; Yamamoto H; Kishimoto S
    Hepatogastroenterology; 1989 Oct; 36(5):393-7. PubMed ID: 2516008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma requirement for expression of lupus-like anticoagulant.
    Clyne LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.
    Ford PM; Ford SE; Lillicrap DP
    J Rheumatol; 1988 Apr; 15(4):597-600. PubMed ID: 3135393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein Z levels and central retinal vein or artery occlusion.
    Koren-Michowitz M; Eting E; Rahimi-Levene N; Garach-Jehoshua O; Volcheck Y; Kornberg A
    Eur J Haematol; 2005 Nov; 75(5):401-5. PubMed ID: 16191090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral combined central retinal artery and vein occlusion in systemic lupus erythematosus resulting in complete blindness.
    Mendrinos E; Mavrakanas N; Kiel R; Pournaras CJ
    Eye (Lond); 2009 May; 23(5):1231-2. PubMed ID: 18535593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.